To identify the poor prognostic factors of MPO-ANCA positive MPA-ILD, we compared baseline clinical and laboratory findings between the 35 MPA-ILD survivors and the 12 MPA-ILD non-survivors (Table 3). The gene discussed is MPO; the disease is interstitial lung disease.